Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Original Article: Peroxisome proliferator‐activated receptor and AMP‐activated protein kinase agonists protect against lethal influenza virus challenge in mice

17 Aug 2010

Abstract excerpt

BACKGROUND: A novel influenza A (H1N1) virus was isolated from humans in North America and has developed into the first pandemic of the 21st century. Reports of a global shortage of antiviral drugs, the evolution of drug-resistant influenza virus variants, and a 6-month delay in vaccine availability underline the need to develop new therapeutics that may be widely distributed during future pandemics. METHODS: In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Metabolism, Diabetes, and Cancer
Share to Peroxisome Proliferator-Activated Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20716159
DOI: 10.1111/j.1750-2659.2010.00155.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Original Article: Peroxisome proliferator‐activated receptor and AMP‐activated protein kinase agonists protect against lethal influenza virus challenge in micePMID 20716159Read ↗

Host Protective Immune Responses against Influenza A Virus Infection.Semantic proximity Read ↗

Quelling the storm: utilization of sphingosine-1-phosphate receptor signaling to ameliorate influenza virus-induced cytokine storm.Semantic proximity Read ↗

Implication of Inflammatory Macrophages, Nuclear Receptors, and Interferon Regulatory Factors in Increased Virulence of Pandemic 2009 H1N1 Influenza A Virus after Host AdaptationSemantic proximity Read ↗

New treatments for influenzaSemantic proximity Read ↗

Influenza pharmacotherapy: present situation, strategies and hopes.Semantic proximity Read ↗

Protection against lethal influenza virus challenge by RNA interference <i>in vivo</i>Semantic proximity Read ↗

Targeting the host or the virus: Current and novel concepts for antiviral approaches against influenza virus infectionSemantic proximity Read ↗

Strong interferon-inducing capacity of a highly virulent variant of influenza A virus strain PR8 with deletions in the NS1 gene.Semantic proximity Read ↗

Prevention of influenza by targeting host receptors using engineered proteinsSemantic proximity Read ↗

A novel Pan-viral prophylaxis strategy using vaccine adjuvant CAF09b protects against influenza virus infectionSemantic proximity Read ↗

Unique and overlapping actions of Type I and III IFNs in influenza A virus infection and implications for therapySemantic proximity Read ↗

Plasmacytoid dendritic cells and Toll-like receptor 7-dependent signalling promote efficient protection of mice against highly virulent influenza A virusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.